Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
- 15 April 2024
- journal article
- review article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 45 (8) , 1533-1555
Abstract
Cancer cells largely rely on aerobic glycolysis or the Warburg effect to generate essential biomolecules and energy for their rapid growth. The key modulators in glycolysis including glucose transporters and enzymes, e.g. hexokinase 2, enolase 1, pyruvate kinase M2, lactate dehydrogenase A, play indispensable roles in glucose uptake, glucose consumption, ATP generation, lactate production, etc. Transcriptional regulation and post-translational modifications (PTMs) of these critical modulators are important for signal transduction and metabolic reprogramming in the glycolytic pathway, which can provide energy advantages to cancer cell growth. In this review we recapitulate the recent advances in research on glycolytic modulators of cancer cells and analyze the strategies targeting these vital modulators including small-molecule inhibitors and microRNAs (miRNAs) for targeted cancer therapy. We focus on the regulation of the glycolytic pathway at the transcription level (e.g., hypoxia-inducible factor 1, c-MYC, p53, sine oculis homeobox homolog 1, N6-methyladenosine modification) and PTMs (including phosphorylation, methylation, acetylation, ubiquitination, etc.) of the key regulators in these processes. This review will provide a comprehensive understanding of the regulation of the key modulators in the glycolytic pathway and might shed light on the targeted cancer therapy at different molecular levels.Keywords
This publication has 279 references indexed in Scilit:
- Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under HypoxiaHepatology, 2021
- Mir‐488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3Journal of Clinical Laboratory Analysis, 2020
- Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3Angewandte Chemie International Edition, 2019
- MicroRNA‐488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3FEBS Open Bio, 2019
- MicroRNA‐450b‐3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinomaJournal of Cellular Biochemistry, 2019
- NK007 helps in mitigating paclitaxel resistance through p38MAPK activation and HK2 degradation in ovarian cancerJournal of Cellular Physiology, 2019
- Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesisHepatology, 2016
- MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancerHepatology, 2015
- The monocarboxylate transporter family—Role and regulationIUBMB Life, 2011
- Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancerJournal of Cellular Physiology, 2004